Concentrix Corporation
Featured
Absci Corporation 2025 Financial Update
Absci Corporation Reports Q4 2025 Loss, Misses EPS Estimate Absci Corporation posted a GAAP loss of $0.
4 minutes ago
MaxCyte 2025 Financial Results Review
MaxCyte, Inc. (MXCT) posted a Q4 2025 GAAP loss of $0.09 per share, wider than the -$0.08 expected loss (10.3% wider).